메뉴 건너뛰기




Volumn 44, Issue 8, 2014, Pages 763-768

P-glycoprotein (P-gp)-mediated efflux limits intestinal absorption of the Hsp90 inhibitor SNX-2112 in rats

Author keywords

ATPase assay; Efflux transporters; Hsp90 inhibitor; P glycoprotein; SNX 2112

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CYCLOSPORIN; ELACRIDAR; GF 120918A; HEAT SHOCK PROTEIN 90 INHIBITOR; MULTIDRUG RESISTANCE PROTEIN; SNX 2112; UNCLASSIFIED DRUG; FUSED HETEROCYCLIC RINGS; HEAT SHOCK PROTEIN 90;

EID: 84904001764     PISSN: 00498254     EISSN: 13665928     Source Type: Journal    
DOI: 10.3109/00498254.2014.891781     Document Type: Article
Times cited : (8)

References (37)
  • 1
    • 63449139456 scopus 로고    scopus 로고
    • Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding
    • Aller SG, Yu J, Ward A, et al. (2009). Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding. Science 323: 1718-22.
    • (2009) Science , vol.323 , pp. 1718-1722
    • Aller, S.G.1    Yu, J.2    Ward, A.3
  • 2
    • 0028948839 scopus 로고
    • A theoretical basis for a biopharmaceutic drug classification: The correlation in vitro drug product dissolution and in vivo bioavailability
    • Amidon GL, Lennernäs H, Shah VP, Crison Jr. (1995). A theoretical basis for a biopharmaceutic drug classification: the correlation in vitro drug product dissolution and in vivo bioavailability. Pharm Res 12: 413-20.
    • (1995) Pharm Res , vol.12 , pp. 413-420
    • Amidon, G.L.1    Lennernäs, H.2    Shah, V.P.3    Crison, J.R.4
  • 3
    • 84882696152 scopus 로고    scopus 로고
    • P-glycoprotein inhibition for optimal drug delivery
    • Amin ML. (2013). P-glycoprotein inhibition for optimal drug delivery. Drug Target Insights 7: 27-34.
    • (2013) Drug Target Insights , vol.7 , pp. 27-34
    • Amin, M.L.1
  • 5
    • 2442719906 scopus 로고    scopus 로고
    • Unmasking the dynamic interplay between efflux transporters and metabolic enzymes
    • DOI 10.1016/j.ijpharm.2002.12.002, PII S0378517304001255
    • Benet LZ, Cummins CL, Wu CY. (2004). Unmasking the dynamic interplay between efflux transporters and metabolic enzymes. Int J Pharm 277: 3-9. (Pubitemid 38670415)
    • (2004) International Journal of Pharmaceutics , vol.277 , Issue.1-2 , pp. 3-9
    • Benet, L.Z.1    Cummins, C.L.2    Wu, C.Y.3
  • 6
    • 30344487254 scopus 로고    scopus 로고
    • Use of P-glycoprotein and BCRP inhibitors to improve oral bioavailability and CNS penetration of anticancer drugs
    • DOI 10.1016/j.tips.2005.11.009, PII S016561470500310X
    • Breedveld P, Beijnen JH, Schellens JH. (2006). Use of P-glycoprotein and BCRP inhibitors to improve oral bioavailability and CNS penetration of anticancer drugs. Trends Pharmacol Sci 27: 17-24. (Pubitemid 43063120)
    • (2006) Trends in Pharmacological Sciences , vol.27 , Issue.1 , pp. 17-24
    • Breedveld, P.1    Beijnen, J.H.2    Schellens, J.H.M.3
  • 8
    • 0037371414 scopus 로고    scopus 로고
    • Metabolism of flavonoids via enteric recycling: Role of intestinal disposition
    • DOI 10.1124/jpet.102.046409
    • Chen J, Lin H, Hu M. (2003). Metabolism of flavonoids via enteric recycling: role of intestinal disposition. J Pharmacol Exp Ther 304: 1228-35. (Pubitemid 36254436)
    • (2003) Journal of Pharmacology and Experimental Therapeutics , vol.304 , Issue.3 , pp. 1228-1235
    • Chen, J.1    Lin, H.2    Hu, M.3
  • 9
    • 84859269331 scopus 로고    scopus 로고
    • Computational models for predicting substrates or inhibitors of P-glycoprotein
    • Chen L, Li Y, Yu H, et al. (2012). Computational models for predicting substrates or inhibitors of P-glycoprotein. Drug Discov Today 17: 343-51.
    • (2012) Drug Discov Today , vol.17 , pp. 343-351
    • Chen, L.1    Li, Y.2    Yu, H.3
  • 10
    • 0033980182 scopus 로고    scopus 로고
    • P-glycoprotein: A defense mechanism limiting oral bioavailability and CNS accumulation of drugs
    • Fromm MF. (2000). P-glycoprotein: a defense mechanism limiting oral bioavailability and CNS accumulation of drugs. Int J Clin Pharmacol Ther 38: 69-74. (Pubitemid 30077981)
    • (2000) International Journal of Clinical Pharmacology and Therapeutics , vol.38 , Issue.2 , pp. 69-74
    • Fromm, M.F.1
  • 11
    • 0242552872 scopus 로고    scopus 로고
    • Importance of P-glycoprotein for drug disposition in humans
    • Fromm MF. (2003). Importance of P-glycoprotein for drug disposition in humans. Eur J Clin Invest 33 Suppl 2: 6-9.
    • (2003) Eur J Clin Invest , vol.33 , Issue.SUPPL. 2 , pp. 6-9
    • Fromm, M.F.1
  • 12
    • 78649661850 scopus 로고    scopus 로고
    • Importance of P-glycoprotein for drug-drug interactions
    • Glaeser H. (2011). Importance of P-glycoprotein for drug-drug interactions. Handb Exp Pharmacol 201: 285-97.
    • (2011) Handb Exp Pharmacol , vol.201 , pp. 285-297
    • Glaeser, H.1
  • 13
    • 0036889665 scopus 로고    scopus 로고
    • Endogenous drug transporters in in vitro and in vivo models for the prediction of drug disposition in man
    • DOI 10.1016/S0006-2952(02)01355-2, PII S0006295202013552
    • Goh LB, Spears KJ, Yao D, et al. (2002). Endogenous drug transporters in in vitro and in vivo models for the prediction of drug disposition in man. Biochem Pharmacol 64: 1569-78. (Pubitemid 35333418)
    • (2002) Biochemical Pharmacology , vol.64 , Issue.11 , pp. 1569-1578
    • Goh, L.-B.1    Spears, K.J.2    Yao, D.3    Ayrton, A.4    Morgan, P.5    Roland Wolf, C.6    Friedberg, T.7
  • 15
    • 67650741952 scopus 로고    scopus 로고
    • Discovery of novel 2-aminobenzamide inhibitors of heat shock protein 90 as potent, selective and orally active antitumor agents
    • Huang KH, Veal JM, Fadden RP, et al. (2009). Discovery of novel 2-aminobenzamide inhibitors of heat shock protein 90 as potent, selective and orally active antitumor agents. J Med Chem 52: 4288-305.
    • (2009) J Med Chem , vol.52 , pp. 4288-4305
    • Huang, K.H.1    Veal, J.M.2    Fadden, R.P.3
  • 16
    • 0027524642 scopus 로고
    • In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative
    • Hyafil F, Vergely C, Du Vignaud P, Grand-Perret T. (1993). In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative. Cancer Res 53: 4595-602. (Pubitemid 23304385)
    • (1993) Cancer Research , vol.53 , Issue.18 , pp. 4595-4602
    • Hyafil, F.1    Vergely, C.2    Du Vignaud, P.3    Grand-Perret, T.4
  • 19
    • 0023940704 scopus 로고
    • Determination of intrinsic membrane transport parameters from perfused intestine experiments: A boundary layer approach to estimating the aqueous and unbiased membrane permeabilities
    • Johnson DA, Amidon GL. (1988). Determination of intrinsic membrane transport parameters from perfused intestine experiments: a boundary layer approach to estimating the aqueous and unbiased membrane permeabilities. J Theor Biol 131: 93-106.
    • (1988) J Theor Biol , vol.131 , pp. 93-106
    • Johnson, D.A.1    Amidon, G.L.2
  • 20
    • 4143108324 scopus 로고    scopus 로고
    • Substrate depletion approach for determining in vitro metabolic clearance: Time dependencies in hepatocyte and microsomal incubations
    • DOI 10.1124/dmd.104.000125
    • Jones HM, Houston JB. (2004). Substrate depletion approach for determining in vitro metabolic clearance: time dependencies in hepatocyte and microsomal incubations. Drug Metab Dispos 32: 973-82. (Pubitemid 39096058)
    • (2004) Drug Metabolism and Disposition , vol.32 , Issue.9 , pp. 973-982
    • Jones, H.M.1    Houston, J.B.2
  • 21
    • 84885089993 scopus 로고    scopus 로고
    • Structure-activity relationships and in silico models of P-glycoprotein (ABCB1) inhibitors
    • Liu H, Ma Z, Wu B. (2013). Structure-activity relationships and in silico models of P-glycoprotein (ABCB1) inhibitors. Xenobiotica 43: 1018-26.
    • (2013) Xenobiotica , vol.43 , pp. 1018-1026
    • Liu, H.1    Ma, Z.2    Wu, B.3
  • 22
    • 84898712261 scopus 로고    scopus 로고
    • Metabolite elucidation of the Hsp90 inhibitor SNX-2112 using ultraperformance liquid chromatography/ quadrupole time-of-flight mass spectrometry (UPLC-QTOF/ MS)
    • (in press), [Epub ahead of print]. doi: 10.3109/00498254.2013.853849
    • Liu W, Liu H, Sun H, et al. (in press). Metabolite elucidation of the Hsp90 inhibitor SNX-2112 using ultraperformance liquid chromatography/ quadrupole time-of-flight mass spectrometry (UPLC-QTOF/ MS). Xenobiotica. [Epub ahead of print]. doi: 10.3109/ 00498254.2013.853849.
    • Xenobiotica
    • Liu, W.1    Liu, H.2    Sun, H.3
  • 23
    • 27644444057 scopus 로고    scopus 로고
    • Unbiased membrane permeability parameters for gabapentin using boundary layer approach
    • DOI 10.1208/aapsj070121, 21
    • Madan J, Chawla G, Arora V, et al. (2005). Unbiased membrane permeability parameters for gabapentin using boundary layer approach. AAPS J 7:E224-30. (Pubitemid 41554286)
    • (2005) AAPS Journal , vol.7 , Issue.1
    • Madan, J.1    Chawla, G.2    Arora, V.3    Malik, R.4    Bansal, A.K.5
  • 24
    • 66149125584 scopus 로고    scopus 로고
    • Targeting HSP90 for cancer therapy
    • Mahalingam D, Swords R, Carew JS, et al. (2009). Targeting HSP90 for cancer therapy. Br J Cancer 100: 1523-9.
    • (2009) Br J Cancer , vol.100 , pp. 1523-1529
    • Mahalingam, D.1    Swords, R.2    Carew, J.S.3
  • 25
    • 84874267225 scopus 로고    scopus 로고
    • The therapeutic target Hsp90 and cancer hallmarks
    • Miyata Y, Nakamoto H, Neckers L. (2013). The therapeutic target Hsp90 and cancer hallmarks. Curr Pharm Des 19: 347-65.
    • (2013) Curr Pharm des , vol.19 , pp. 347-365
    • Miyata, Y.1    Nakamoto, H.2    Neckers, L.3
  • 26
    • 59649086503 scopus 로고    scopus 로고
    • SNX-2112, a selective Hsp90 inhibitor, potently inhibits tumor cell growth, angiogenesis, and osteoclastogenesis in multiple myeloma and other hematologic tumors by abrogating signaling via Akt and ERK
    • Okawa Y, Hideshima T, Steed P, et al. (2009). SNX-2112, a selective Hsp90 inhibitor, potently inhibits tumor cell growth, angiogenesis, and osteoclastogenesis in multiple myeloma and other hematologic tumors by abrogating signaling via Akt and ERK. Blood 113: 846-55.
    • (2009) Blood , vol.113 , pp. 846-855
    • Okawa, Y.1    Hideshima, T.2    Steed, P.3
  • 27
    • 73949109329 scopus 로고    scopus 로고
    • Expression and function of p-glycoprotein in normal tissues: Effect on pharmacokinetics
    • Staud F, Ceckova M, Micuda S, Pavek P. (2010). Expression and function of p-glycoprotein in normal tissues: effect on pharmacokinetics. Methods Mol Biol 596: 199-222.
    • (2010) Methods Mol Biol , vol.596 , pp. 199-222
    • Staud, F.1    Ceckova, M.2    Micuda, S.3    Pavek, P.4
  • 28
    • 79851478871 scopus 로고    scopus 로고
    • Predicting drugdrug interactions involving the inhibition of intestinal CYP3A4 and P-glycoprotein
    • Tachibana T, Kato M, Takano J, Sugiyama Y. (2010). Predicting drugdrug interactions involving the inhibition of intestinal CYP3A4 and P-glycoprotein. Curr Drug Metab 11: 762-77.
    • (2010) Curr Drug Metab , vol.11 , pp. 762-777
    • Tachibana, T.1    Kato, M.2    Takano, J.3    Sugiyama, Y.4
  • 29
    • 0036293772 scopus 로고    scopus 로고
    • Are MDCK cells transfected with the human MDR1 gene a good model of the human intestinal mucosa?
    • DOI 10.1023/A:1016140429238
    • Tang F, Horie K, Borchardt RT. (2002). Are MDCK cells transfected with the human MDR1 gene a good model of the human intestinal mucosa? Pharm Res 19: 765-72. (Pubitemid 34686734)
    • (2002) Pharmaceutical Research , vol.19 , Issue.6 , pp. 765-772
    • Tang, F.1    Horie, K.2    Borchardt, R.T.3
  • 30
    • 0033975157 scopus 로고    scopus 로고
    • Role of P-glycoprotein in drug disposition
    • DOI 10.1097/00007691-200002000-00029
    • Tanigawara Y. (2000). Role of P-glycoprotein in drug disposition. Ther Drug Monit 22: 137-40. (Pubitemid 30083115)
    • (2000) Therapeutic Drug Monitoring , vol.22 , Issue.1 , pp. 137-140
    • Tanigawara, Y.1
  • 32
    • 14644419054 scopus 로고    scopus 로고
    • Functional role of P-glycoprotein in limiting intestinal absorption of drugs: Contribution of passive permeability to P-glycoprotein mediated efflux transport
    • DOI 10.1021/mp0499196
    • Varma MV, Sateesh K, Panchagnula R. (2005). Functional role of P-glycoprotein in limiting intestinal absorption of drugs: contribution of passive permeability to P-glycoprotein mediated efflux transport. Mol Pharm 2: 12-21. (Pubitemid 40314725)
    • (2005) Molecular Pharmaceutics , vol.2 , Issue.1 , pp. 12-21
    • Varma, M.V.S.1    Sateesh, K.2    Panchagnula, R.3
  • 33
    • 81855206518 scopus 로고    scopus 로고
    • Drug-permeability and transporter assays in Caco-2 and MDCK cell lines
    • Volpe DA. (2011). Drug-permeability and transporter assays in Caco-2 and MDCK cell lines. Future Med Chem 3: 2063-77.
    • (2011) Future Med Chem , vol.3 , pp. 2063-2077
    • Volpe, D.A.1
  • 34
    • 25844519550 scopus 로고    scopus 로고
    • HSP90 and the chaperoning of cancer
    • DOI 10.1038/nrc1716
    • Whitesell L, Lindquist SL. (2005). HSP90 and the chaperoning of cancer. Nat Rev Cancer 5: 761-72. (Pubitemid 41400776)
    • (2005) Nature Reviews Cancer , vol.5 , Issue.10 , pp. 761-772
    • Whitesell, L.1    Lindquist, S.L.2
  • 35
    • 71949113516 scopus 로고    scopus 로고
    • Disposition of naringenin via glucuronidation pathway is affected by compensating efflux transporters of hydrophilic glucuronides
    • Xu H, Kulkarni KH, Singh R, et al. (2009). Disposition of naringenin via glucuronidation pathway is affected by compensating efflux transporters of hydrophilic glucuronides. Mol Pharm 6: 1703-15.
    • (2009) Mol Pharm , vol.6 , pp. 1703-1715
    • Xu, H.1    Kulkarni, K.H.2    Singh, R.3
  • 36
    • 80053155942 scopus 로고    scopus 로고
    • Enhancement of oral bioavailability of 20(S)-ginsenoside Rh2 through improved understanding of its absorption and efflux mechanisms
    • Yang Z, Gao S, Wang J, et al. (2011). Enhancement of oral bioavailability of 20(S)-ginsenoside Rh2 through improved understanding of its absorption and efflux mechanisms. Drug Metab Dispos 39: 1866-72.
    • (2011) Drug Metab Dispos , vol.39 , pp. 1866-1872
    • Yang, Z.1    Gao, S.2    Wang, J.3
  • 37
    • 80053221096 scopus 로고    scopus 로고
    • Poor oral bioavailability of a promising anticancer agent andrographolide is due to extensive metabolism and efflux by P-glycoprotein
    • Ye L, Wang T, Tang L, et al. (2011). Poor oral bioavailability of a promising anticancer agent andrographolide is due to extensive metabolism and efflux by P-glycoprotein. J Pharm Sci 100: 5007-17.
    • (2011) J Pharm Sci , vol.100 , pp. 5007-5017
    • Ye, L.1    Wang, T.2    Tang, L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.